Omnicell logo

Omnicell

Omnicell sells IV compounding robots, IVX Workflow software, and an IV Compounding Service for hospital pharmacies. Group revenue was $1.185 billion in 2025, far above our usual band, so this is a short scored profile of its IV room robotics.1,2

Robotics Reviewed Editorial TeamUpdated November 16, 2026omnicell.com

Our take

Omnicell offers IV compounding robots, semi-automated IVX Workflow software, and an IV Compounding Service that combines robots, analytics, and onsite experts so hospitals can compound more IV doses in house.1

It suits health systems that want to cut outsourcing and buy IV automation as a managed service. Allegheny General Hospital reports $1.5 million in annual savings.1

Scores by criterion

Omnicell scores out of 10
Pricing transparency3.0
Product maturity7.5
Deployment evidence7.5
Company durability8.5
Ease of integration7.0
Overall score (average of the five)6.7

Pricing transparency, 3.0: Omnicell publishes no prices; the IV Compounding Service is sold as a partnership with shared objectives.1

Product maturity, 7.5: The IV room line spans robotics, smart devices, software, and services.1

Deployment evidence, 7.5: Omnicell cites Allegheny General Hospital, which saved $1.5 million a year by reducing outsourcing and operating room waste.1

Company durability, 8.5: Omnicell revenue was $1.185 billion in 2025, up 7 percent.2

Ease of integration, 7.0: The service model includes onsite and remote experts, which eases rollout but ties the hospital to Omnicell.1

Each criterion is defined on our methodology page.

Who uses Omnicell and what it's for

The buyer is a hospital or health system pharmacy that compounds IV doses and wants to bring more of that work in house.1

IV room automation

The IV room line combines compounding robots, IVX Workflow for semi-automated compounding, and the IV Compounding Service.1,3

Pricing

Omnicell quotes IV room systems and services by contract.1

Competitive landscape

Which of these companies scores best, and who is each one built for?Hover over or tap a logo for details.
Top rated, for smaller operationsTop rated, for large enterprisesLower score, for smaller operationsLower score, for large enterprisesNot yet reviewed45678910Review Score← Smaller operationsLarge enterprises →Who it's built for6.76.46.16.7
Omnicell and its competitors
CompanyProductPricing modelDeployment footprintWhere Omnicell wins or loses
OmnicellIV compounding robots, IVX Workflow software, IV Compounding Service1Service contracts; by quote1Allegheny General saves $1.5 million a year1Pharmacy automation group; above band
ARxIUMRIVA IV robot plus packagers, cabinets, and inventory software4Not published; consultation12More than 19 million RIVA doses5ARxIUM wins on RIVA IV compounding robots with a long record. Omnicell wins on IV automation sold as a managed service.
EQUASHIELD ProAutomated hazardous drug compounder using closed transfer devices7Not published; quote7Equashield sells on five continents8Equashield wins on closed-system compounding for hazardous drugs. Omnicell wins on IV automation sold as a managed service.
KIRO OncologyTwo-arm hazardous drug compounder with gravimetric checks9Not published; quote9Part of the inclusiv IV compounding portfolio13Kiro wins on automated compounding for chemotherapy. Omnicell wins on IV automation sold as a managed service.
Loccioni APOTECAchemoAPOTECAchemo IV chemotherapy compounding robot11Not published11User community across the US, Europe, the Gulf, and Asia11APOTECA wins on oncology compounding robots from Italy. Omnicell wins on IV automation sold as a managed service.

Limits

Revenue far above our usual band.2

No published prices.1

Service contracts tie hospitals to one vendor.1

What customers say

Where it helps

IV compounding automation sold as a managed service.1

Where it falls short

Contract pricing only.1

Company backing

Omnicell is listed on NASDAQ. Founder Randall Lipps is chairman, president, and chief executive officer.2

    Sources